References
- Piérard G, Arrese J, Piérard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs 1996;52 (2):209–224.
- Drake LA, Dinehart SM, Farmer ER, Goltz RW,et al . Guidelines of care for superficial mycotic infections of the skin: Tinea corporis, Tinea curis, Tinea faciei, Tinea manuum and Tinea pedis. J. Am. Acad. Dermatol. 1996;34 (2 pt.1):282–286.
- Laura K, Stephanie DT, Christopher JP, Charles LC, David MS. Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay. Endocrine Res. 2002;28 (3):129–140.
- El-laithy HM, El-Shaboury KMF. The development of cutina lipogel and gel microemulsion for topical administration of fluconazole. AAPS. PharmSciTech. 2002;3: art. 35.
- Fekete Pal, Virgula J. Fluconazole capsules with improved release. Patent No., WO2005002553, 2005.
- Gilis PMV, Conde VFV. Beads having a core coated with an antifungal and a polymer. US Patent No., US5633015, 1997.
- Lo JB. Method of producing porous delivery devices. Patent No., WO 93/18757, 1993.
- Brenman B, Leyden JJ. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J. Am. Acad. Dermatol. 1997;36 (1):53–58.
- Pattnaik S, Subramanyam VR, Bapaji M, Kole CR. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios. 1997;89 (358):39–46.
- Moleyar V, Narasimham P. Mode of antifungal action of essential oil components citral and camphor. Indian J. Exp. Biol. 1987;25 (11):781–784.
- Bamba M, Puisievx F, Marty J, Carstensen J. Release mechanism in gel forming sustained release formulation. Int. J. Pharm. 1979;2 (5–6):307–315.
- Gibaldi M, Feldman S.Establishment of sink conditions in dissolution rate determination. J. Pharm. Sci. 1967;56 (10):1238–1242.
- Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983;15 (1):25–35.
- Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J. Pharm. Sci. 1961;50 (10):874–875.
- Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963;52 (12):1145–1149.
- Higuchi I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 1962;51 (8):802–804.
- Langenbucher F. Linearization of dissolution rate curves by the weibull distribution. J. Pharm. Pharmacol. 1972;24 (12):979–989.
- Schwarz J, Weisspapir M. Vehicle for topical delivery of anti-inflammatory compounds. Patent No., WO/2006/096955, 2006.
- Warren R, Reed J. Topical tanning compositions. Patent No., EP19870306848, 1989.
- Suresh M, Nadakatti VN. Detergent bar and process for manufacture. US Patent No., US20060287206, 2006.
- In-Kwon H,Young K, Hung-Sik K, Donggeun S, Woon-Won J, Hee JC, Yu-Kyoung O. Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 2006;38 (2):106–111.
- Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: A blueprint for the future of antifungal susceptibility testing. Clin. Microbiol. Rev. 2006;19 (2):435–447.
- Kahn M. Bioavailability of vitamin B12 using a small-volume nebulizer ophthalmic drug delivery system. Clin. Experim. Ophthalmol. 2005;33 (4):402–407.
- Chew NYK, Reed BL, Morgan TM, Finnin BC. Topical delivery of antifungal agents. US Patent No., US20040081684, 2004.
- Friedlander SF. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of Tinea capitis. Pediatr. Infect. Dis. J. 1999;18 (2):205–210.